Patents Assigned to Vita Genomics, Inc.
  • Patent number: 7604945
    Abstract: A gene related to a susceptibility of infection and asthma—the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene—a method of detecting the asthma-associated gene, a method of predicting the occurrence of asthma, a method of identifying asthma-associated alleles in PTPRD gene, a method of screening PTPRD for drugs useful in the treatment of asthma, and antibodies specific for PTPRD variants and their use in diagnostic assays.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: October 20, 2009
    Assignee: Vita Genomics, Inc.
    Inventors: Shih Hsin Wu, Ellson Ye-Shyon Chen
  • Publication number: 20080187932
    Abstract: A gene related to a susceptibility of infection and asthma—the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene—a method of detecting the asthma-associated gene, a method of predicting the occurrence of asthma, a method of identifying asthma-associated alleles in PTPRD gene, a method of screening PTPRD for drugs useful in the treatment of asthma, and antibodies specific for PTPRD variants and their use in diagnostic assays.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 7, 2008
    Applicant: Vita Genomics, Inc.
    Inventors: Shih Hsin Wu, Ellson Ye-Shyon Chen
  • Patent number: 7405043
    Abstract: Sets of nucleic acids and methods for predicting a subject's responsiveness to therapy for liver disorders.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: July 29, 2008
    Assignee: Vita Genomics, Inc.
    Inventors: Yuchi Hwang, Kuang-Den Chen, Chingwei Chang, Jui-Lin Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Publication number: 20070161006
    Abstract: A gene related to a susceptibility of infection and asthma—the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene—a method of detecting the asthma-associated gene, a method of predicting the occurrence of asthma, a method of identifying asthma-associated alleles in PTPRD gene, a method of screening PTPRD for drugs useful in the treatment of asthma, and antibodies specific for PTPRD variants and their use in diagnostic assays.
    Type: Application
    Filed: January 10, 2006
    Publication date: July 12, 2007
    Applicant: Vita Genomics, Inc.
    Inventors: Shihi Hsin Wu, Ellson Ye-Shyon Chen
  • Patent number: 7108978
    Abstract: It is provided isolated polynucleotides that include sequences from genomic region around the gene CD 81. The polynucleotides include polymorphisms associated with treatment response of HCV patients to interferon-? and ribavirin combined therapy and are useful as the probes in screening for patients who will response to interferon-? and ribavirin combined therapy. It is further provided linkage disequilibrium structure of the CD81 gene and haplotype information within a particular LD block, which can be used for prediction of the treatment outcome of the interferon-? and ribavirin combined therapy on HCV patients.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: September 19, 2006
    Assignee: Vita Genomics, Inc.
    Inventors: Jui-Lin Chen, Yuchi Hwang, Min-Pey Ding, Wen-Pi Chu, Shu-Ching Wang, Kuei-Ling Belinda Chen, Wan-Lin Yao, Kuang-Den Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Publication number: 20050288497
    Abstract: Sets of nucleic acids and methods for predicting a subject's responsiveness to therapy for liver disorders.
    Type: Application
    Filed: June 29, 2004
    Publication date: December 29, 2005
    Applicant: Vita Genomics, Inc.
    Inventors: Yuchi Hwang, Kuang-Den Chen, Chingwei Chang, Jui-Lin Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai